Regional lymphadenopathy following COVID-19 vaccination: considerations for primary care management

Br J Gen Pract. 2021 May 27;71(707):284-285. doi: 10.3399/bjgp21X716117. Print 2021 Jun.

Authors

Emanuele Garreffa¹, Joanne York¹, Anne Turnbull¹, Denise Kendrick²

Affiliations

¹ Royal Derby Hospital, Derby.
² University of Nottingham, Nottingham.

No abstract available

MeSH terms

COVID-19 Vaccines
COVID-19*
Humans
Lymphadenopathy*
Primary Health Care
SARS-CoV-2
Vaccination

Substances

COVID-19 Vaccines